By Rob Chang, CEO & Director of Gryphon Digital Mining Inc. (Nasdaq: GRYP) At the start of January 2024, the Bitcoin mining sector hit a significant milestone with its sustainable energy usage peaking at over 50%. This achievement is more...

From left to right: Kate Sylvester, Scott Deveau and Rebecca Kral.   By Karen Roman Longacre Square Partners named two new partners and appointed a COO, people familiar with the matter told CorpGov. The communications and special situations advisory firm...

By Karen Roman Agendia, Inc.’s BluePrint was recently included in the latest version of German Gynecological Oncology Group (AGO) guidelines for chemotherapy decision making. AGO is comprised of gynecological oncologists specialized in breast cancer and interdisciplinary members focused on pathology,...

By Daniella Parra Gameto, a female-led biotechnology firm, said it received tentative FDA approval to move to Phase 3 trials for Fertilo, a pivotal step towards Biologic License Application approval, the company said. The primary efficacy endpoint will assess pregnancy...

By Karen Roman Orthobond Corp. said the Food and Drug Administration approved its request to market Ostaguard, an antibacterial surface treatment used on permanent spine implants. This is the first time the FDA granted approval for a medical device with...

By Karen Roman Acumen Pharmaceuticals, Inc. (Nasdaq: ABOS), a clinical-stage biopharmaceutical company, announced it signed an agreement with global pharmaceutical and biotech partner Lonza. The collaboration includes the manufacturing of sabirnetug (ACU193), an antibody for the treatment of Alzheimer’s disease...

By Karen Roman Gryphon Digital Mining, Inc. (Nasdaq: GRYP) said its performance achieved a bitcoin efficiency of 49 BTC/EH in its operational update for March. That equals February’s self-mining outcome, when Gryphon’s score tied 2nd and when its peers who...

By Exec Edge Editorial Staff In the rapidly evolving landscape of autonomous mobility and robotics, Light Detection and Ranging (LiDAR) technology stands as a cornerstone for the development of intelligent systems capable of perceiving and interacting with their environment. Among...

By Daniella Parra Gameto, a biotech firm focused on women’s healthcare, shared a study examining the impact of minimal controlled ovarian stimulation on egg retrieval experiences. The analysis involved 110 patients with minimal stimulation cycles followed by OSC-IVM, 48 patients...

By Karen Roman REGENXBIO Inc. (Nasdaq: RGNX), a clinical-stage biotechnology company, said its subretinal treatment of age-related macular degeneration showed improved vision in patients. Two years of data were published in The Lancet regarding the ongoing trials of ABBV-RGX-314, its...